CoreCap Advisors’s Soleno Therapeutics SLNO Stock Holding History

CoreCap Advisors’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$134	–	3274
2026 Q1	$134	Hold	4	–	–	﹤0.01%	2807
2025 Q4	$185	Sell	4 -3	-43%	-$164	﹤0.01%	2822
2025 Q3	$473	Buy	7 +5	+250%	+$371	﹤0.01%	2577
2025 Q2	$168	Sell	2 -3	-60%	-$225	﹤0.01%	2641
2025 Q1	$357	Buy	+5	New	+$243	﹤0.01%	2777

CoreCap Advisors's SLNO Position: Q2 2026 in Review

CoreCap Advisors sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 4 shares — an estimated $134 sold.

CoreCap Advisors first reported a position in SLNO in Q1 2025 and held it in 5 quarters. The position peaked at $473 in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

CoreCap Advisors reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
CoreCap Advisors sold 4 Soleno Therapeutics shares in Q2 2026, an estimated $134.
CoreCap Advisors first reported a position in Soleno Therapeutics in Q1 2025 and held it in 5 quarters.
CoreCap Advisors's Soleno Therapeutics position peaked at $473 in Q3 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.